BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cavero I, Seimetz D, Koziel D, Zimmermann WH, Holzgrefe HH. 19th Annual Meeting of the Safety Pharmacology Society: regulatory and safety perspectives for advanced therapy medicinal products (cellular and gene therapy products). Expert Opin Drug Saf. 2020;19:553-558. [PMID: 32163309 DOI: 10.1080/14740338.2020.1741546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kugener VF, Freedland ES, Maynard KI, Aimer O, Webster PS, Salas M, Gossell-Williams M. Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities. Drug Saf 2021;44:843-52. [PMID: 33993430 DOI: 10.1007/s40264-021-01078-8] [Reference Citation Analysis]
2 Loh EYX, Goh PS, Mannan AMM, Mohd Sani N, Ab Ghani A. Cell and gene therapy products in Malaysia: a snapshot of the industry's current regulation preparedness. Cytotherapy 2021:S1465-3249(21)00714-3. [PMID: 34362651 DOI: 10.1016/j.jcyt.2021.06.006] [Reference Citation Analysis]